HSIC – Henry Schein, Inc. – Fundamental analysis, financial statements, key ratios, and fair value analysis

Henry Schein, Inc.

Healthcare
Medical Distribution
74.5
0.73
0.99%
90.4
63.44
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)2.56
EPS Estimate Currrent Qtr1.11
Book Value Per Share19.5
Market Cap 11 Billion
PE Ratio 28.8
Dividend YieldNA

Stock Yield

Stock Return 7 Days4.79%
Stock Return 15 Days-2.28%
Stock Return 30 Days -13.81%
Stock Return 3 Months-9.67%
Stock Return One Year9.02%
Stock Return 3 Years9.86%

Stock Technical Analysis

Relative Strengh Index (14)21.15
Average True Range (14)2.58
Momentum (14)-11.35
Simple Moving Average (14) -11.35
Time Series Forecast (14)74.84
Time Series Forecast (30) 89.08

Stock News

NewsSourcePublished
See what the IHS Markit Score report has to say about Henry Schein Inc.Yahoo Finance01/05/2019 13:03
HENRY SCHEIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Henry Schein, Inc. – HSICYahoo Finance01/05/2019 03:50
5 Health Care Stocks Gurus Are BuyingYahoo Finance01/03/2019 17:27
Baird softens view on Henry Schein; shares slip 3%Seeking Alpha01/02/2019 11:59
Report: Exploring Fundamental Drivers Behind Cronos Group, Henry Schein, Argo Group International, Eiger BioPharmaceuticals, China Automotive, and Moleculin Biotech — New Horizons, Emerging Trends, and Upcoming DevelopmentsYahoo Finance12/31/2018 12:30
HS Spinco, Inc. Files Registration Statement With U.S. Securities And Exchange Commission For Spin Off Of Henry Schein’s Animal Health Business And Subsequent Merger With Vets First ChoiceYahoo Finance12/26/2018 22:20
Henry Schein and Vets First Choice Announce New Name of the Planned New Company: CovetrusYahoo Finance12/20/2018 22:43
A Look At The Fair Value Of Henry Schein, Inc. (NASDAQ:HSIC)Yahoo Finance12/20/2018 13:03
Henry Schein To Present At The 2019 J.P. Morgan Healthcare ConferenceYahoo Finance12/19/2018 13:23
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Board of Directors of Henry Schein, Inc. (HSIC) and Encourages HSIC Investors to Contact the FirmYahoo Finance12/18/2018 21:42
CareCredit Now Integrated Into Henry Schein’s Dental And Veterinary Practice Management Software SolutionsYahoo Finance12/17/2018 13:05
HENRY SCHEIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Henry Schein, Inc. – HSICYahoo Finance12/15/2018 03:50
Should You Buy Henry Schein, Inc. (HSIC)?Yahoo Finance12/14/2018 04:34
Henry Schein announces $400M increase to share repurchase planSeeking Alpha12/13/2018 08:17
Henry Schein Announces $400 Million Increase To Share Repurchase PlanYahoo Finance12/13/2018 13:00

Financial Statements

index2014201520162017
Revenue10 Billion11 Billion12 Billion12 Billion
Cost of Revenue7 Billion8 Billion8 Billion9 Billion
Gross Profit3 Billion3 Billion3 Billion3 Billion
Gross Margin (%)28.07%28.29%27.88%27.28%
Selling General and Administrative Expense2 Billion2 Billion2 Billion3 Billion
Other operating expenses9 Million52 Million61 Million37 Million
Earning Before Interest and Taxes EBIT706 Million716 Million757 Million822 Million
EBIT/Operating Margin (%)6.80%6.74%6.54%6.60%
Interest Expense24 Million26 Million32 Million54 Million
Other non-operating expenses/income0000
Earnings before Tax682 Million690 Million725 Million769 Million
Income Tax Expense216 Million211 Million218 Million363 Million
Net Income466 Million479 Million507 Million406 Million
Net Margin (%)4.49%4.51%4.38%3.26%
Earnings per share from operating income0.5566990.5247560.4816190.787654
Earnings per Diluted Share2.722.853.12.57
Dividends per Basic Common Share0000
Weighted average number of shares outstanding171 Million168 Million163 Million158 Million
index2017 Q42018 Q12018 Q22018 Q3
Revenue3 Billion3 Billion3 Billion3 Billion
Cost of Revenue2 Billion2 Billion2 Billion2 Billion
Gross Profit901 Million896 Million901 Million889 Million
Gross Margin (%)27.15%27.81%27.09%27.09%
Selling General and Administrative Expense660 Million686 Million677 Million668 Million
Other operating expenses27 Million4 Million18 Million49 Million
Earning Before Interest and Taxes EBIT214 Million206 Million206 Million172 Million
EBIT/Operating Margin (%)6.46%6.38%6.19%5.24%
Interest Expense17 Million18 Million18 Million21 Million
Other non-operating expenses/income0000
Earnings before Tax198 Million188 Million188 Million151 Million
Income Tax Expense206 Million48 Million47 Million29 Million
Net Income-9 Million140 Million141 Million121 Million
Net Margin (%)-0.00%4.35%4.24%3.70%
Earnings per share from operating income627.6891.610681.585761.79148
Earnings per Diluted Share-00.910.920.79
Dividends per Basic Common Share0000
Weighted average number of shares outstanding213 Million154 Million153 Million154 Million
index2014201520162017
Cash and Equivalents89 Million72 Million62 Million175 Million
Trade and Non Trade Receivables1 Billion1 Billion1 Billion2 Billion
Inventory1 Billion2 Billion2 Billion2 Billion
Other current assets547 Million563 Million485 Million804 Million
Current Assets3 Billion3 Billion3 Billion4 Billion
Total Non-Current Assets3 Billion3 Billion3 Billion4 Billion
Total Assets6 Billion7 Billion7 Billion8 Billion
Trade and Non Trade Payables861 Million1 Billion1 Billion1 Billion
Other current liabilities919 Million1 Billion1 Billion2 Billion
Current Liabilities2 Billion2 Billion2 Billion3 Billion
Liabilities Non Current978 Million929 Million1 Billion1 Billion
Accumulated Retained Earnings Deficit3 Billion3 Billion3 Billion3 Billion
Shareholder’s equity other171 Million-12 Million-189 Million-129 Million
Shareholders Equity3 Billion3 Billion3 Billion3 Billion
Noncontrolling interests4 Billion5 Billion5 Billion7 Billion
Total Assets6 Billion7 Billion7 Billion8 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents175 Million99 Million111 Million120 Million
Trade and Non Trade Receivables2 Billion2 Billion2 Billion2 Billion
Inventory2 Billion2 Billion2 Billion2 Billion
Other current assets804 Million629 Million682 Million753 Million
Current Assets4 Billion4 Billion4 Billion4 Billion
Total Non-Current Assets4 Billion4 Billion4 Billion4 Billion
Total Assets8 Billion8 Billion8 Billion8 Billion
Trade and Non Trade Payables1 Billion1 Billion1 Billion1 Billion
Other current liabilities2 Billion2 Billion2 Billion2 Billion
Current Liabilities3 Billion3 Billion3 Billion3 Billion
Liabilities Non Current1 Billion1 Billion1 Billion1 Billion
Accumulated Retained Earnings Deficit3 Billion3 Billion3 Billion3 Billion
Shareholder’s equity other-129 Million-96 Million-210 Million-218 Million
Shareholders Equity3 Billion3 Billion3 Billion3 Billion
Noncontrolling interests7 Billion6 Billion7 Billion7 Billion
Total Assets8 Billion8 Billion8 Billion8 Billion
index2014201520162017
Net Cash Flow from Operations593 Million616 Million643 Million546 Million
Capital Expenditure-82 Million-72 Million-70 Million-82 Million
Net Cash Flow from Investing-517 Million-260 Million-316 Million-342 Million
Net Cash Flow from Financing-155 Million-348 Million-327 Million-113 Million
Cash and Equivalents89 Million72 Million62 Million175 Million
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations238 Million-71 Million288 Million174 Million
Capital Expenditure-26 Million-18 Million-20 Million-23 Million
Net Cash Flow from Investing-21 Million-35 Million-39 Million-72 Million
Net Cash Flow from Financing-129 Million28 Million-250 Million-96 Million
Cash and Equivalents175 Million99 Million111 Million120 Million

Stock Price History

table